These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6627809)

  • 1. Interindividual variations in drug disposition. Clinical implications and methods of investigation.
    Breimer DD
    Clin Pharmacokinet; 1983; 8(5):371-7. PubMed ID: 6627809
    [No Abstract]   [Full Text] [Related]  

  • 2. [The metabolic clearance rate of antipyrine: a good index for the assessment of the hepatic drug-oxidizing function in cirrhotic patients (author's transl)].
    Miguet JP; Allemand H; Joanne C; Dhumeaux D
    Nouv Presse Med; 1978 Dec; 7(46):4209-11. PubMed ID: 745958
    [No Abstract]   [Full Text] [Related]  

  • 3. Dose-dependent effect of propafenone on in vivo drug metabolism in the rat.
    Chong MT; Svensson CK
    Res Commun Chem Pathol Pharmacol; 1987 Nov; 58(2):147-56. PubMed ID: 3423421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug oxidation in Asian vegetarians.
    Mucklow JC; Rawlins MD; Brodie MJ; Boobis AR; Dollery CT
    Lancet; 1980 Jul; 2(8186):151. PubMed ID: 6105323
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of the drug metabolism capacity of the liver.
    Park BK
    Br J Clin Pharmacol; 1982 Nov; 14(5):631-51. PubMed ID: 6128018
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment of methods to identify sources of interindividual pharmacokinetic variations.
    Vesell ES; Penno MB
    Clin Pharmacokinet; 1983; 8(5):378-409. PubMed ID: 6194927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interindividual differences in drug oxidation: clinical importance.
    Sjöqvist F; von Bahr C
    Drug Metab Dispos; 1973; 1(1):469-82. PubMed ID: 4149420
    [No Abstract]   [Full Text] [Related]  

  • 8. Antipyrine half-life and drug elimination.
    Breckenridge A
    Clin Pharmacokinet; 1980; 5(3):201-3. PubMed ID: 7389234
    [No Abstract]   [Full Text] [Related]  

  • 9. Interindividual differences in rates of drug oxidation in man.
    Davies DS; Thorgeirsson SS; Breckenridge A; Orme M
    Drug Metab Dispos; 1973; 1(1):411-7. PubMed ID: 4149412
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic factors in hepatic drug oxidation.
    Kalow W; Inaba T
    Prog Liver Dis; 1976; 5():246-58. PubMed ID: 775542
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug metabolism in uremia.
    Reidenberg MM
    Clin Nephrol; 1975; 4(3):83-5. PubMed ID: 1102176
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of nifedipine on hepatic drug oxidation.
    Dickinson TH; Egan JM; Abernethy DR
    Pharmacology; 1988; 36(6):405-10. PubMed ID: 3420161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic heat exposure on drug metabolism in the rat.
    Ben Zvi Z; Kaplanski J
    J Pharm Pharmacol; 1980 May; 32(5):368-9. PubMed ID: 6104708
    [No Abstract]   [Full Text] [Related]  

  • 14. [In vivo activity of drug-metabolizing enzymes in various pathological conditions].
    Krakovskiĭ ME; Ashirmetov AKh
    Vopr Med Khim; 1985; 31(1):76-9. PubMed ID: 3984279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P-450 and drug oxidation.
    Davies DS
    Biochem J; 1969 Dec; 115(5):23P-24P. PubMed ID: 4391248
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of vitamin C supplement on antipyrine disposition in man.
    Houston JB
    Br J Clin Pharmacol; 1977 Apr; 4(2):236-9. PubMed ID: 861139
    [No Abstract]   [Full Text] [Related]  

  • 17. A new polymorphism of hepatic drug oxidation in man: family studies on rates of formation of antipyrine metabolites.
    Vessell ES; Penno MB
    Biochem Soc Trans; 1984 Feb; 12(1):74-8. PubMed ID: 6705993
    [No Abstract]   [Full Text] [Related]  

  • 18. Impairment of drug elimination in patients with liver disease.
    Narang AP; Datta DV; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):28-32. PubMed ID: 3988389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipyretic analgesic drugs as models for studies of drug disposition in old age.
    Greenblatt DJ; Abernethy DR; Divoll M; Ochs HR; Shader RI
    Am J Med; 1983 Nov; 75(5A):127-32. PubMed ID: 6606360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the different metabolic pathways of antipyrine as a tool in the assessment of the activity of different drug metabolizing enzyme systems in man [proceedings].
    Van Boxtel CJ; Breimer DD; Danhof M
    Br J Pharmacol; 1980 Jan; 68(1):121P. PubMed ID: 7357141
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.